CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $157,000 | -39.1% | 10,000 | -36.3% | 0.00% | 0.0% |
| Q1 2018 | $258,000 | -75.4% | 15,700 | -71.1% | 0.00% | -83.3% |
| Q3 2017 | $1,050,000 | +101.1% | 54,400 | +22.8% | 0.01% | +100.0% |
| Q2 2017 | $522,000 | -45.6% | 44,300 | -49.4% | 0.00% | -62.5% |
| Q1 2017 | $960,000 | +59.2% | 87,600 | +5.5% | 0.01% | +100.0% |
| Q4 2016 | $603,000 | +210.8% | 83,000 | +60.9% | 0.00% | +300.0% |
| Q3 2015 | $194,000 | -89.6% | 51,600 | -83.4% | 0.00% | -90.9% |
| Q2 2015 | $1,868,000 | – | 310,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |